These findings show that at least some haematopoetic growth factors cannot rescue leukaemic cells treated with RUNX1-CBFA2T1 siRNAs, and suggest that targeting of leukaemic cells with such siRNAs in vivo might interfere with the development and maintenance of leukaemia. Here, RUNX1 is linked to leukemia.